The Degenerative Disc Disease market report provides current treatment practices, emerging drugs, Degenerative Disc Disease (DDD) market share of the individual therapies, current and forecasted Degenerative Disc Disease (DDD) market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Degenerative Disc Disease (DDD) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Degenerative Disc Disease Overview
Degenerative Disk Disease (DDD- osteochondrosis intervertebralis) is a common disorder that is characterized by a progressive degeneration of the intervertebral disc; rendering them deformed and mechanically dysfunctional. It is a catchall phrase for a number of structural changes of the spine, such as loss of disc height, disc bulges, hydration, and impingement of nerves in the spine, among others.
Request free sample copy- https://www.delveinsight.com/sample-request/degenerative-disc-disease-ddd-market
Regions covered in the report
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
List of companies involved in the report
- Mesoblast and Gruenthal
- DiscGenics
- And many others
Degenerative Disc Disease Symptoms
Symptoms of degenerative disc disease are most commonly found in the low back or neck. The pain may range from mild to severe and disabling, primarily affect the neck and lower back, extend to the arms and hands, radiate to the buttocks and thighs, worsen when sitting or after bending, lifting or twisting, cause weakness in the leg muscles or foot drop, which may be a sign of damage to the nerve root.
Degenerative Disc Disease Diagnosis
DDD can be diagnosed through imaging tests like X-rays, a magnetic resonance imaging scan (MRI) or computed tomography (CT) scan which can get a better look at the discs and bony structure.
Degenerative Disc Disease Treatment
DDD can often be managed conservatively through physical therapy, chiropractic manipulative therapy, osteopathic manipulation, anti-inflammatory medications, such as non-steroidal anti-inflammatory drugs (NSAIDs), and/or spinal injections, epidural steroid injections that can provide pain relief. If these more moderate approaches fail to alleviate symptoms, surgery may be necessary.
Degenerative Disc Disease Market Report
Resultant loss of structural and functional integrity of the spine can lead to lumbar and/or cervical pain syndromes; the discs are unable to fulfill their primary functions of cushioning and providing mobility between the vertebrae; consequently DDD has been reported as a leading cause of low back pain. Disc degeneration, although in many cases asymptomatic, is also associated with sciatica and disc herniation or prolapse.
Degenerative Disc Disease Market Insights
The radiographic findings of DDD can be found in 40% of individuals younger than 30 and in more than 90% of individuals older than 50 years of age. DDD can be treated pharmacologically with opiates, steroids, or non-steroidal anti-inflammatory drugs. Likewise, other conservative measures such as physical therapy and corticosteroid injections are frequently prescribed. However, these measures do not treat the underlying cause of the degenerative process and do not slow the natural progression of the disease. Given the potential complications of surgical interventions, attention to biologic-based therapies for DDD has gained traction.
Request free sample copy- https://www.delveinsight.com/sample-request/degenerative-disc-disease-ddd-market
Table of content
1. Key Insights
2. Executive Summary of Degenerative Disc Disease (DDD)
3. Competitive Intelligence Analysis for Degenerative Disc Disease (DDD)
4. Degenerative Disc Disease (DDD): Market Overview at a Glance
5. Degenerative Disc Disease (DDD): Disease Background and Overview
6. Patient Journey
7. Degenerative Disc Disease (DDD) Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Degenerative Disc Disease (DDD) Treatment
11. Marketed Products
12. Emerging Therapies
13. Degenerative Disc Disease (DDD): Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Degenerative Disc Disease (DDD)
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Degenerative Disc Disease Market Drivers
- Rich emerging pipeline
- Increasing Incidence of DDD
- Increasing cause of low back pains & neck pain in adults and increasing geriatric population
Degenerative Disc Disease Market Barriers
- Impact on quality of life of the patient
- Failure to recognize the condition delays commencement of more appropriate care
Degenerative Disc Disease Market Report Highlights
- Daily activities and sports causes tears in the outer core of the disc. By age 60, most people have some degree of disc degeneration. However, not everyone at that age has back pain.
- The increase in Market Size is mainly expected to be driven by increasing incident pool, rising funding, clinical trials of degenerative disk disease and expected entries of emerging therapies in the 7MM.
Why should you buy this report?
- The report will help in developing business strategies by understanding trends shaping and driving the Degenerative Disc Disease (DDD) market
- To understand the future market competition in the Degenerative Disc Disease (DDD) market and Insightful review of the key market drivers and barriers
- Organize sales and marketing efforts by identifying the best opportunities for Degenerative Disc Disease (DDD) in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
- Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
- Organize sales and marketing efforts by identifying the best opportunities for Degenerative Disc Disease (DDD) market
- To understand the future market competition in the Degenerative Disc Disease (DDD) market
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
